Genetic determinants of type 2 diabetes mellitus

被引:43
作者
Busch, CP [1 ]
Hegele, RA [1 ]
机构
[1] John P Robarts Res Inst, Blackburn Cardiovasc Genet Lab, London, ON N6A 5K8, Canada
关键词
complex disease; diabetes; insulin resistance; metabolic syndrome; polygenic trait;
D O I
10.1034/j.1399-0004.2001.600401.x
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Type 2 diabetes refers to a group of disparate metabolic diseases, which are typically characterized by insulin resistance in peripheral tissues, together with impaired insulin secretion from pancreatic beta -cells. The complexity of type 2 diabetes is related to factors such as genetic heterogeneity, interactions between genes, and the modulating role played by the environment. Recent progress has included defining the molecular basis of monogenic forms of type 2 diabetes, such as familial partial lipodystrophy and the subtypes of maturity-onset diabetes of the young (MODY), and also the identification of chromosomal regions that may harbor type 2 diabetes susceptibility genes. Many common variants in functional and positional candidate genes, including ADRB3, PPARG, ENPP1, and CAPN10, have also been studied for their possible role as determinants of type 2 diabetes, with varying levels of agreement between studies. The availability of a relatively complete sequence of the human genome will increase the amount of genetic information that can be used to evaluate hypotheses for the genetic basis of type 2 diabetes. To make sense of human type 2 diabetes in the post-genomic era, it is essential to have well-defined phenotypes in addition to sufficient numbers of individuals with the appropriate pedigree structure from families and/or communities.
引用
收藏
页码:243 / 254
页数:12
相关论文
共 113 条
[1]   The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes [J].
Altshuler, D ;
Hirschhorn, JN ;
Klannemark, M ;
Lindgren, CM ;
Vohl, MC ;
Nemesh, J ;
Lane, CR ;
Schaffner, SF ;
Bolk, S ;
Brewer, C ;
Tuomi, T ;
Gaudet, D ;
Hudson, TJ ;
Daly, M ;
Groop, L ;
Lander, ES .
NATURE GENETICS, 2000, 26 (01) :76-80
[2]  
[Anonymous], 1997, Diabetes Care, V20 Suppl 1, pS1
[3]   Adrenoceptor genes in human obesity [J].
Arner, P ;
Hoffstedt, J .
JOURNAL OF INTERNAL MEDICINE, 1999, 245 (06) :667-672
[4]   2 MEMBERS OF AN HNF1 HOMEOPROTEIN FAMILY ARE EXPRESSED IN HUMAN LIVER [J].
BACH, I ;
MATTEI, MG ;
CEREGHINI, S ;
YANIV, M .
NUCLEIC ACIDS RESEARCH, 1991, 19 (13) :3553-3559
[5]   A calpain-10 gene polymorphism is associated with reduced muscle mRNA levels and insulin resistance [J].
Baier, LJ ;
Permana, PA ;
Yang, XL ;
Pratley, RE ;
Hanson, RL ;
Shen, GQ ;
Mott, D ;
Knowler, WC ;
Cox, NJ ;
Horikawa, Y ;
Oda, N ;
Bell, GI ;
Bogardus, C .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 106 (07) :R69-R73
[6]   Association of the Pro12Ala variant in the peroxisome proliferator-activated receptor-γ2 gene with obesity in two Caucasian populations [J].
Beamer, BA ;
Yen, CJ ;
Andersen, BE ;
Muller, D ;
Elahi, D ;
Cheskin, LJ ;
Andres, R ;
Roth, J ;
Shuldiner, AR .
DIABETES, 1998, 47 (11) :1806-1808
[7]   Human type 1 diabetes and the insulin gene: Principles of mapping polygenes [J].
Bennett, ST ;
Todd, JA .
ANNUAL REVIEW OF GENETICS, 1996, 30 :343-370
[8]   IRS proteins and β-cell function [J].
Burks, DJ ;
White, MF .
DIABETES, 2001, 50 :S140-S145
[9]   PARTIAL LIPOATROPHY WITH INSULIN RESISTANT DIABETES AND HYPERLIPEMIA (DUNNIGAN SYNDROME) [J].
BURN, J ;
BARAITSER, M .
JOURNAL OF MEDICAL GENETICS, 1986, 23 (02) :128-130
[10]   Nuclear lamin A/C R482Q mutation in Canadian kindreds with Dunnigan-type familial partial lipodystrophy [J].
Cao, H ;
Hegele, RA .
HUMAN MOLECULAR GENETICS, 2000, 9 (01) :109-112